SG175568A1 - Photochemical therapy to affect mechanical and/or chemical properties of body tissue - Google Patents

Photochemical therapy to affect mechanical and/or chemical properties of body tissue Download PDF

Info

Publication number
SG175568A1
SG175568A1 SG2011070554A SG2011070554A SG175568A1 SG 175568 A1 SG175568 A1 SG 175568A1 SG 2011070554 A SG2011070554 A SG 2011070554A SG 2011070554 A SG2011070554 A SG 2011070554A SG 175568 A1 SG175568 A1 SG 175568A1
Authority
SG
Singapore
Prior art keywords
photoinitiator
tissue
ocular
compound
myopia
Prior art date
Application number
SG2011070554A
Other languages
English (en)
Inventor
Daniel M Schwartz
Matthew S Mattson
Julia A Kornfield
Robert K Maloney
Robert H Grubbs
Original Assignee
California Inst Of Techn
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Inst Of Techn, Univ California filed Critical California Inst Of Techn
Publication of SG175568A1 publication Critical patent/SG175568A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/0079—Methods or devices for eye surgery using non-laser electromagnetic radiation, e.g. non-coherent light or microwaves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00865—Sclera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00872—Cornea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00885—Methods or devices for eye surgery using laser for treating a particular disease
    • A61F2009/00893—Keratoconus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Electromagnetism (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG2011070554A 2006-10-24 2007-10-24 Photochemical therapy to affect mechanical and/or chemical properties of body tissue SG175568A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85394906P 2006-10-24 2006-10-24
US95454107P 2007-08-07 2007-08-07

Publications (1)

Publication Number Publication Date
SG175568A1 true SG175568A1 (en) 2011-11-28

Family

ID=39325405

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2011070554A SG175568A1 (en) 2006-10-24 2007-10-24 Photochemical therapy to affect mechanical and/or chemical properties of body tissue

Country Status (5)

Country Link
US (1) US8414911B2 (cg-RX-API-DMAC10.html)
JP (1) JP5559540B2 (cg-RX-API-DMAC10.html)
KR (2) KR101502632B1 (cg-RX-API-DMAC10.html)
SG (1) SG175568A1 (cg-RX-API-DMAC10.html)
WO (1) WO2008052081A2 (cg-RX-API-DMAC10.html)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
US8580789B2 (en) * 2007-04-02 2013-11-12 The Cleveland Clinic Foundation Treating glaucoma
US8545487B2 (en) * 2007-12-05 2013-10-01 Avedro Inc. Eye therapy system
CZ18420U1 (cs) * 2008-01-25 2008-04-07 Benedík@Jaroslav Prístroj na zjištování kvality a pevnosti cévní steny
US20110060267A1 (en) * 2008-03-14 2011-03-10 Dewoolfson Bruce Ultraviolet irradiation to treat corneal weakness disorders
GB0816399D0 (en) * 2008-09-09 2008-10-15 Sharma Anant Irradiation treatment
WO2010039854A1 (en) * 2008-09-30 2010-04-08 Neal Marshall Eye therapy system
KR20180023070A (ko) 2008-11-07 2018-03-06 클록스 테크놀로지스 인크. 히알루론산, 글루코사민 또는 알란토인을 포함하는 산화성의 광활성화된 피부 회춘용 조성물
SG177635A1 (en) 2009-07-17 2012-03-29 Klox Technologies Inc Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
US20110077468A1 (en) * 2009-09-30 2011-03-31 Finger Paul T Drug eluting eyelid speculum
WO2011050164A1 (en) 2009-10-21 2011-04-28 Avedro, Inc. Eye therapy
DE102010008146B4 (de) * 2010-02-12 2022-03-31 Carl Zeiss Meditec Ag Messsystem und Verfahren zum Ermitteln des Innendrucks eines Auges sowie Verfahren und System zum Einstellen des Augeninnendrucks
WO2011116306A2 (en) 2010-03-19 2011-09-22 Avedro, Inc. Systems and methods for applying and monitoring eye therapy
DE102010020194B4 (de) 2010-05-07 2022-09-08 Carl Zeiss Meditec Ag Vorrichtung zur Stabilisierung der Augenhornhaut
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
WO2012154627A2 (en) * 2011-05-06 2012-11-15 California Institute Of Technology Light delivery device and related compositions, methods and systems
WO2012162529A1 (en) 2011-05-24 2012-11-29 Avedro, Inc. Systems and methods for reshaping an eye feature
WO2012167260A2 (en) 2011-06-02 2012-12-06 Avedro, Inc. Systems and methods for monitoring time based photo active agent delivery or photo active marker presence
ES2856698T3 (es) 2011-08-23 2021-09-28 Yeda Res & Dev Fotosensibilizadores de (bacterio)clorofila para el tratamiento de enfermedades y trastornos oculares
EP2830554A1 (en) 2012-03-29 2015-02-04 CXL Ophthalmics, LLC Ocular cross-linking system and method for sealing corneal wounds
US9566301B2 (en) 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
EP4420725A3 (en) 2012-03-29 2025-04-16 Epion Therapeutics, Inc. Ocular treatment solutions, delivery devices and delivery augmentation methods
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
EP2872081B2 (en) 2012-07-16 2025-07-16 Avedro, Inc. Systems for corneal cross-linking with pulsed light
BR112015005593B1 (pt) 2012-09-14 2019-09-24 Valeant Pharmaceuticals International, Inc. Método para branqueamento de dentes
DE102013004482A1 (de) 2013-03-12 2014-09-18 Carl Zeiss Meditec Ag Vorrichtung und Verfahren zur Stabilisierung der Augenhornhaut
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
EP3441049B1 (en) * 2013-03-14 2025-08-20 Epion Therapeutics, Inc. Ophthalmic treatment device
WO2014205145A1 (en) 2013-06-18 2014-12-24 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
US9498114B2 (en) 2013-06-18 2016-11-22 Avedro, Inc. Systems and methods for determining biomechanical properties of the eye for applying treatment
WO2015000058A1 (en) 2013-07-03 2015-01-08 Klox Technologies Inc. Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds
US9920147B2 (en) 2013-09-13 2018-03-20 Brandeis University Polymeric materials having active cross-linkers, methods for making them, and use thereof
JP2017509433A (ja) 2014-04-01 2017-04-06 クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． 組織充填剤組成物および使用方法
EP3212140B1 (en) 2014-10-27 2021-12-01 Avedro, Inc. Systems for cross-linking treatments of an eye
EP3212826B1 (en) 2014-10-31 2020-10-14 Klox Technologies Inc. Photoactivatable fibers and fabric media
US10114205B2 (en) 2014-11-13 2018-10-30 Avedro, Inc. Multipass virtually imaged phased array etalon
EP3827792A1 (en) 2015-04-24 2021-06-02 Avedro, Inc. Systems and methods for photoactivating a photosensitizer applied to an eye
WO2016183424A1 (en) 2015-05-14 2016-11-17 California Institute Of Technology Light adjustable intraocular lenses using upconverting nanop articles and near infrared (nir) light
EP4483884A3 (en) 2015-05-22 2025-03-05 Avedro Inc. Systems for monitoring cross-linking activity for corneal treatments
WO2017015471A1 (en) 2015-07-21 2017-01-26 Avedro, Inc. Systems and methods for treaments of an eye with a photosensitizer
WO2017096400A1 (en) 2015-12-03 2017-06-08 Avedro, Inc. Systems and methods for treating an eye with a mask device
DE102016208012A1 (de) 2016-05-10 2017-11-16 Carl Zeiss Meditec Ag Augenchirurgisches Verfahren
WO2019005943A1 (en) 2017-06-28 2019-01-03 California Institute Of Technology LIGHT ADJUSTABLE INTRAOCULAR LENSES USING ASCENDING CONVERSION OF HEART-WOOD NANOPARTICLES AND INFRARED NEAR-LIGHT (NIR)
US12042433B2 (en) 2018-03-05 2024-07-23 Avedro, Inc. Systems and methods for eye tracking during eye treatment
EP3761928B1 (en) 2018-03-08 2026-07-22 Avedro, Inc. Micro-devices for treatment of an eye
CA3112937A1 (en) 2018-09-19 2020-03-26 Avedro, Inc. Systems and methods treating for corneal ectatic disorders
CN113316411B (zh) 2018-09-19 2025-01-17 艾维德洛公司 用于眼部治疗期间的眼部追踪的系统及方法
AU2019356934B2 (en) 2018-10-09 2024-10-17 Avedro, Inc. Photoactivation systems and methods for corneal cross-linking treatments
US11702546B2 (en) 2018-10-24 2023-07-18 California Institute Of Technology Near-infrared heptamethine dyes for generation of singlet oxygen
CN111140774B (zh) * 2019-01-31 2025-10-14 中国科学院昆明动物研究所 一种可抑制眼轴过度增长的新型光源及其模拟方法、灯具
WO2020176598A1 (en) 2019-02-26 2020-09-03 Avedro, Inc. Systems and methods for cross-linking treatments of an eye
JP6853446B2 (ja) * 2019-02-28 2021-03-31 地方独立行政法人神奈川県立産業技術総合研究所 流動体試料の内部構造観察装置及び内部構造解析システム、流動体試料の内部構造観察方法及び内部構造解析方法、並びにセラミックスの製造方法
US11298263B2 (en) * 2019-07-16 2022-04-12 Jack T. Holladay Method of mitigating myopia development and related instrumentation
AU2020326998B2 (en) 2019-08-06 2024-08-22 Avedro, Inc. Photoactivation systems and methods for corneal cross-linking treatments
CA3213111A1 (en) 2021-03-08 2022-09-15 Avedro, Inc. Systems and methods for generating patient-specific corneal cross-linking treatment patterns
DE102021131244A1 (de) * 2021-11-29 2023-06-01 Philipps-Universität Marburg, Körperschaft des öffentlichen Rechts Orts- und zeitaufgelöste Bestimmung der dermalen Penetration von nicht- oder schwachfluoreszierenden Substanzen
WO2025255364A1 (en) * 2024-06-07 2025-12-11 The Regents Of The University Of California Methods and devices for transscleral multiphoton imaging and laser therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6161544A (en) 1998-01-28 2000-12-19 Keratoform, Inc. Methods for accelerated orthokeratology
JP2002058695A (ja) 1999-09-03 2002-02-26 Carl Zeiss Jena Gmbh 眼の照射方法及び装置
WO2005110397A1 (en) 2004-05-07 2005-11-24 The Regents Of The University Of California Treatment of myopia
US20060276777A1 (en) * 2005-04-08 2006-12-07 Coroneo Minas T Corneal shaping
WO2007001926A2 (en) 2005-06-24 2007-01-04 Hyperbranch Medical Technology, Inc. Low-swelling hydrogel sealants for wound repair

Also Published As

Publication number Publication date
WO2008052081A2 (en) 2008-05-02
WO2008052081A8 (en) 2008-08-14
KR101551590B1 (ko) 2015-09-08
KR20090082392A (ko) 2009-07-30
KR20140096371A (ko) 2014-08-05
JP2010507686A (ja) 2010-03-11
US20080114283A1 (en) 2008-05-15
US8414911B2 (en) 2013-04-09
WO2008052081A3 (en) 2008-06-19
KR101502632B1 (ko) 2015-03-17
JP5559540B2 (ja) 2014-07-23

Similar Documents

Publication Publication Date Title
US8414911B2 (en) Photochemical therapy to affect mechanical and/or chemical properties of body tissue
US7727544B2 (en) Treatment of myopia
JP4975440B2 (ja) 黄斑変性およびその他の眼科疾患の改善
AU2016256894B2 (en) Methods of delivering an agent to the eye
US20150359668A1 (en) Light delivery device and related compositions, methods and systems
EP1904108B1 (en) Ophthalmological formulation comprising methylsulfonylmethane and ciprofloxacin
CN101594904A (zh) 影响身体组织的机械和/或化学性能的光化学治疗
CN1753683A (zh) 预防和治疗不良眼部病症的眼用制剂
JP2009501726A (ja) 眼科学的活性剤の製剤とその投与の方法
EP2620144A1 (en) Staining Composition
US9694010B2 (en) Therapeutic formulation and methods of treatment
AU777655B2 (en) Ophthalmic histamine compositions and uses thereof
Hao et al. Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Nakamura et al. Persistence of retinal indocyanine green dye following vitreous surgery
Miller Ocular emergencies
RU2408335C1 (ru) Способ лечения возрастной макулярной дегенерации сетчатки
Everaert Evaluation of newly developed HPMC ophthalmic inserts with sustained release properties as a carrier for thermolabile therapeutics
HK1139342A (en) Photochemical therapy to affect mechanical and/or chemical properties of body tissue
EP0665022A1 (en) Viscoelastic solution of N,O-carboxymethyl chitosan for ophthalmic use
RU2822406C1 (ru) Способ подготовки склерального аллотрансплантата для склеропластики при прогрессирующей дегенеративной миопии
Zakirova et al. Preclinical research of mesenchymal stem cell-based therapy for ocular diseases
Kislitsyna et al. Diagnosis and the Classification of Idiopathic Macular Holes
Giuliano Ocular emergencies I.
Hafezi Cross-linking of corneal collagen with UVA and riboflavin for the treatment of corneal disease
Pinelli et al. First Laboratory Report